Q BioMed Inc (OTCQB: $QBIO) to Present at the
Global Chinese Financial Forum on April 30, 2016
Toronto, ON
Conference Expects to Attract Over 200 Participants
NEW
YORK - April 26, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO),
a biotechnology acceleration company, today announced that the company will
present at the Global Chinese Financial Forum (GCFF). The GCFF is the most
prominent series of bi-lingual financial functions in both North America and
China. Established in 2000, GCFF's mandate is to provide a world-class platform
connecting both the Asian and North American financial markets. GCFF assembles
companies, financial institutions and investors who are interested in exploring
new investment ideas and financial opportunities.
The
conference is being held at the Marriott Courtyard Hotel in Markham, Ontario
Canada at 7095 Woodbine Ave, Markham, Ontario.
The
conference runs from 9am to 5pm. Q BioMed CEO, Denis Corin, will present at
10:20am.
Organizers
expect the conference to attract over 200 participants consisting of
pre-qualified investors, industry executives and professional service
providers.
To
stay informed on Q BioMed developments please visit our website http://www.qbiomed.com and sign up for our
news distribution.
About GCFF - GLOBAL CHINESE
FINANCIAL FORUM
Organized
by NAI Interactive, the Global Chinese Financial Forum (GCFF) is the most
prominent series of bi-lingual financial functions in both North America and
China. Established in 2000, GCFF's mandate is to provide a world-class platform
connecting both the Asian and North American financial markets. We assemble
companies, financial institutions and investors who are interested in exploring
new investment ideas and financial opportunities.
With
an extensive network covering both the North American and Chinese market
alongside expertise in the global capital market, GCFF is supported by a strong
foundation of financial resources. It enables GCFF to organize resourceful
financial events that facilitate business growth and networks among financial
institutions, public corporations, private companies, and investors of all
levels.
In
the past 16 years, over 35 GCFF conferences have been held in multiple
locations worldwide including Vancouver, Toronto and China. The latest LNG
Investment Conference was held in April 2014 to enlighten the Chinese community
on the latest LNG development in British Columbia. The conference attracted
over 200 participants consisting of pre-qualified investors, industry
executives and professional service providers.
About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and
development company. We are focused on acquiring companies and biomedical
assets. Q is dedicated to providing these target companies and assets,
strategic resources, developmental support, and expansion capital to ensure
they meet their developmental potential enabling them to provide products to patients
in need.
Forward-Looking
Statements:
This
press release may contain “forward-looking statements” within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such statements include, but are not limited to, any statements
relating to our growth strategy and product development programs and any other
statements that are not historical facts. Forward-looking statements are based
on management’s current expectations and are subject to risks and uncertainties
that could negatively affect our business, operating results, financial
condition and stock price. Factors that could cause actual results to differ
materially from those currently anticipated are: risks related to our growth
strategy; risks relating to the results of research and development activities;
our ability to obtain, perform under and maintain financing and strategic
agreements and relationships; uncertainties relating to preclinical and
clinical testing; our dependence on third-party suppliers; our ability to
attract, integrate, and retain key personnel; the early stage of products under
development; our need for substantial additional funds; government regulation;
patent and intellectual property matters; competition; as well as other risks
described in our SEC filings. We expressly disclaim any obligation or
undertaking to release publicly any updates or revisions to any forward looking
statements contained herein to reflect any change in our expectations or any
changes in events, conditions or circumstances on which any such statement is
based, except as required by law.
Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435
Sign up for the
free investor news and stock alerts:
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party
sourced news, articles and equity research as well as creates original content,
including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investment involves risk and
possible loss of investment. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure:
QBIO has retained investorideas.com for PR, media, news publication and social
media effective February 5th for three months: two thousand five hundred per
month.
Additional info regarding BC Residents and global Investors:
Effective September 15 2008 - all BC investors should review all OTC and Pink
sheet listed companies for adherence in new disclosure filings and filing
appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global
investors must adhere to regulations of each country.
No comments:
Post a Comment